StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a research report report published on Saturday morning. The brokerage issued a sell rating on the stock.
Separately, HC Wainwright raised their price objective on SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a research report on Thursday, December 12th.
Get Our Latest Report on SenesTech
SenesTech Trading Down 8.2 %
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Recommended Stories
- Five stocks we like better than SenesTech
- Why Are These Companies Considered Blue Chips?
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Using the MarketBeat Dividend Tax Calculator
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- What is Short Interest? How to Use It
- MarketBeat Week in Review – 02/24 – 02/28
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.